Advances in Speech Tech for Dysarthria Patientsby Lilu Anderson 29.09.2024New study improves voice recognition for dysarthria, aiding Parkinson's patients with communication.
Why Eli Lilly Stock is the ‘Nvidia’ of GLP-1 Medsby Mark Eisenberg 23.09.2024Investing in Eli Lilly now could mimic early Nvidia gains in AI. Learn why GLP-1 drugs are transforming healthcare investing.
AI Revolutionizes Drug Discovery Market by 2032by Lilu Anderson 03.09.2024AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
Lilly’s Affordable Zepbound Vials: A Game Changerby Mark Eisenberg 27.08.2024Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
Epic Systems Unveils 100+ AI Features for Healthcareby Lilu Anderson 22.08.2024Epic Systems introduces 100+ new AI features to enhance healthcare operations for doctors and patients.
AI-Driven Breakthrough in Protein Design Unveiledby Lilu Anderson 17.08.2024AI-designed proteins transform with molecular switches, paving new paths in biotechnology innovation and drug delivery.
Top Defensive Biotech Stocks Amid Market Turmoilby Lilu Anderson 10.08.2024Discover Piper Sandler's eight high-quality defensive biotech stocks poised to thrive in volatile markets.
McLaren Cyber Attack Disrupts Systemsby Lilu Anderson 08.08.2024McLaren Health Care faces a major cyber attack, disrupting phone and computer systems but maintaining patient care. Experts are investigating.
McLaren Health Care Faces IT and Telephone Systems Disruptionby Lilu Anderson 07.08.2024McLaren Health Care is experiencing IT and phone system outages, impacting patient services. The health system is working to resolve ...
Amgen’s Q2 Revenue Rises 20% Despite Higher Expensesby Mark Eisenberg 07.08.2024Amgen's Q2 profit drops due to higher expenses, but revenue sees a 20% increase, driven by Horizon acquisition.